LD-2 disclosure · 2nd Quarter - Report
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
Client
- Name
- OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
- Description
- Pharmaceutical research and development
- Location
- Maryland · United States of America
Registrant
- Description
- Law firm
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
2 issuesCopyright/Patent/Trademark
The Innovation Act (H.R. 9); Helping Families in Mental Health Crisis Act (H.R. 2646); Mental Health Reform Act of 2015 (H.R. 1945); Mental Health Awareness and Improvement Act (S. 1893).
Lobbyistsmr MATTHEW TODD TUTEN · ELI TOMAR · HEIDE BAJNRAUH · JOHN JONAS · RICHARD THOMPSON
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
H.R. 2646, the Helping Families in Mental Health Crisis Act; H.R. 2690, Strengthening Mental Health In Our Communities Act; H.R. 6, 21st Century Cures initiative; S. 481, Improving Regulatory Transparency for New Medical Therapies Act
Lobbyistsmr MATTHEW TODD TUTEN · ELI TOMAR · HEIDE BAJNRAUH · JOHN JONAS · RICHARD THOMPSON
TargetedSENATE · HOUSE OF REPRESENTATIVES